Basic HTML Version
PRO-Kinetic: results from an “all-comers” single centre
clinical experience
Ran Kornowski*, MD, FESC, FACC; Hana Vaknin-Assa, MD; Shimrit Ukabi, Msc; Eli I. Lev, MD;
Abid Assali, MD
Division of Interventional Cardiology, Rabin Medical Center, Petach Tikva and the “Sackler” Faculty of Medicine, Tel Aviv
University, Tel Aviv, Israel
The authors have no conflict of interest to declare.
- 1 -
Abstract
Aims:
To conduct a clinical registry of consecutive “real world” patients treated using the PRO-Kinetic stent
at Rabin Medical Centre between January 2006 and March 2008.
Methods and results:
Our study included 515 consecutive patients treated for 540 lesions. We had 100%
follow up rate by six months. The patients’ characteristics are noted for 43% rate of diabetics and 17%
renal insufficiency. Indications for angioplasty included patients with either stable of unstable clinical
scenarios and 60% of lesions were of class B2/C. The mean RVD was 2.81mm and lesions length was
12.6 mm prior to PCI and with angiographic success in 99.8% of treated lesions. The six month clinical
outcome data were as follow: MACE rate of 8.7% with 3.5% total mortality, 1.9% cardiac mortality, 1.4% of
any MI and TVR rate of 6.4% per treated patient and 6.7% per treated lesion and 0.4% rate of stent
thrombosis.
Conclusions:
Based on our findings, 1) The PRO-Kinetic clinical data shows excellent results on a large
group of coronary patients, treated consecutively. 2) The data should emphasise the remaining role of ‘state
of the art’ non DES platforms (i.e. such as PRO-Kinetic) for patients with a wide variety of characteristics
and/or clinical syndromes.
KEYWORDS
Coronary artery
disease, bare metal
stent, complex lesions
Clinical research
* Corresponding author: Division of Interventional Cardiology, Rabin Medical Center, 39 Jabotinsky Road, Petah Tikva (49100), Israel
E-mail: rkornowski@clalit.org.il \ ran.kornowski.gmail.com
© Europa Edition. All rights reserved.
EuroInterv.2009;5:
1-00